SIREN : 879960292
INJECT ISOLATION is a French company founded 6 years ago, specialized in the sector Travaux d'isolation. Based in ALES (30100), this company of category PME shows in 2021 a revenue of 329 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2021 |
|---|---|
| Revenue | 328 521 € |
| Net income | 77 824 € |
| EBITDA | 107 758 € |
| Net margin | 23.7% |
In 2021, INJECT ISOLATION achieves revenue of 329 k€. After deducting consumption (80 k€), gross margin stands at 248 k€, i.e. a rate of 76%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 108 k€, representing 32.8% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 78 k€, i.e. 23.7% of revenue. This profit can be retained or distributed to shareholders.
328 521 €
248 369 €
107 758 €
99 948 €
77 824 €
32.6%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 1%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Cash flow represents 25.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
1.279%
0.953%
25.708%
0.0
85.3%
In 2021, the debt ratio of INJECT ISOLATION (1.28) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2021, the financial autonomy of INJECT ISOLATION (0.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2021, the repayment capacity of INJECT ISOLATION (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 295.28. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
295.281
0.0
In 2021, the liquidity ratio of INJECT ISOLATION (295.28) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2021, the interest coverage of INJECT ISOLATION (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 46 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 38 days. The company must finance 8 days of gap between collections and payments. Overall, WCR represents 8 days of revenue, i.e. 7 k€ to permanently finance.
7 487 €
46 j
38 j
0 j
8 j
Based on 58 transactions of similar company sales
(all years),
the value of INJECT ISOLATION is estimated at
143 671 €
(range 95 547€ - 348 747€).
With an EBITDA of 107 758€, the sector multiple of 1.2x is applied.
The price/revenue ratio is 0.20x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 58 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare INJECT ISOLATION with other companies in the same sector:
The revenue of INJECT ISOLATION in 2021 is 329 k€.
Yes, INJECT ISOLATION generated a net profit of 78 k€ in 2021.
The headquarters of INJECT ISOLATION is located in ALES (30100), in the department Gard.
The tax return of INJECT ISOLATION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
INJECT ISOLATION operates in the sector Travaux d'isolation (NAF code 43.29A). See the 'Sector positioning' section above to compare the company with its competitors.